Compare OBIO & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBIO | USBC |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | |
| Employees | N/A | 24 |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 221.2M |
| IPO Year | N/A | N/A |
| Metric | OBIO | USBC |
|---|---|---|
| Price | $3.95 | $0.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.25 | N/A |
| AVG Volume (30 Days) | ★ 219.1K | N/A |
| Earning Date | 11-10-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,818,000.00 | N/A |
| Revenue This Year | $36.66 | N/A |
| Revenue Next Year | $2.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $2.20 | N/A |
| 52 Week High | $6.02 | N/A |
| Indicator | OBIO | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 34.17 |
| Support Level | $3.46 | $0.43 |
| Resistance Level | $4.24 | $0.54 |
| Average True Range (ATR) | 0.31 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 45.70 | 4.89 |
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research. USBC has implemented a Bitcoin treasury strategy to support development and research across its various divisions. A key focus is the further development of its tokenized deposit program, a tokenized representation of a U.S.-dollar-denominated bank deposit account that operates on blockchain technology and is embedded with digital identity, alongside its legacy non-invasive sensor technology business, with the objective of creating long-term shareholder value in an evolving financial landscape.